Literature DB >> 11666979

Synthesis of trans-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine Opioid Antagonists: Application of the Cis-Thermal Elimination of Carbonates to Alkaloid Synthesis.

John A. Werner1, Louis R. Cerbone, Scott A. Frank, Jeffrey A. Ward, Parviz Labib, Roger W. Tharp-Taylor, C. W. Ryan.   

Abstract

Improved syntheses of twotrans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists from 1,3-dimethyl-4-piperidinone are described. The 1,3-dimethyl-4-arylpiperidinol 23 was selectively dehydrated in a two step process to the 1,3-dimethyl-4-aryl-1,2,3,6-tetrahydropyridine 26 by the cis-thermal elimination of the corresponding alkyl carbonate derivative at 190 degrees C. In the presence of a basic nitrogen, the success of the elimination was found to be critically dependent upon the nature of the carbonate alkyl group, with Et, i-Bu, and i-Pr being preferred (90% yield). Alkylation of the metalloenamine, formed by deprotonation of 26 with n-BuLi, proceeded regio- and stereospecifically to give the trans-3,4-dimethyl-4-aryl-1,2,3,4-tetrahydropyridine 27, which was converted in three steps to the common intermediate, (3R,4R)-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine. LY255582, a centrally-active opioid antagonist, and LY246736-dihydrate, a peripherally-active opioid antagonist, were prepared from 1,3-dimethyl-4-piperidinone in 11.8% yield (8 steps) and 6.2% yield (12 steps), respectively.

Entities:  

Year:  1996        PMID: 11666979     DOI: 10.1021/jo951403y

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  Design, Synthesis, and Biological Evaluation of Structurally Rigid Analogues of 4-(3-Hydroxyphenyl)piperidine Opioid Receptor Antagonists.

Authors:  Scott P Runyon; Chad M Kormos; Moses G Gichinga; S Wayne Mascarella; Hernán A Navarro; Jeffrey R Deschamps; Gregory H Imler; F Ivy Carroll
Journal:  J Org Chem       Date:  2016-08-02       Impact factor: 4.354

2.  Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of the 3- and 4-methyl substituents.

Authors:  F Ivy Carroll; Moses G Gichinga; Chad M Kormos; Rangan Maitra; Scott P Runyon; James B Thomas; S Wayne Mascarella; Ann M Decker; Hernán A Navarro
Journal:  Bioorg Med Chem       Date:  2015-08-25       Impact factor: 3.641

3.  The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone.

Authors:  D T Beattie; M Cheruvu; N Mai; M O'Keefe; S Johnson-Rabidoux; C Peterson; E Kaufman; R Vickery
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-06       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.